Immune checkpoint inhibitor therapy in a liver transplant recipient with a rare subtype of melanoma: a case report and literature review.
Melanoma Res. 2017 Nov 14;:
Characteristics of liver transplant candidates delisted following recompensation and predictors of such delisting in alcohol-related liver disease: a case-control study.
Transpl Int. 2017 Jul 07;:
Early Intervention With Live Donor Liver Transplantation Reduces Resource Utilization in NASH: The Toronto Experience.
Transplant Direct. 2017 Jun;3(6):e158
Transpl Infect Dis. 2017 Mar 22;:
Liver Transplantation is a Preferable Alternative to Palliative Therapy for Selected Patients with Advanced Hepatocellular Carcinoma.
Ann Surg Oncol. 2017 Feb 03;:
Sofosbuvir-Based Antiviral Therapy Is Highly Effective In Recurrent Hepatitis C in Liver Transplant Recipients: Canadian Multicenter "Real-Life" Experience.
Transplantation. 2016 Mar 4;
Post-transplant lymphoproliferative disorder in liver recipients: Characteristics, management, and outcome from a single-centre experience with >1000 liver transplantations.
Can J Gastroenterol Hepatol. 2015 Jun 15;
Identifying candidates with favorable prognosis following liver transplantation for hepatocellular carcinoma: Data mining analysis.
J Surg Oncol. 2015 May 29;
High sustained virological response to pegylated interferon and ribavirin for recurrent genotype 3 hepatitis C infection post-liver transplantation.
Hepatol Int. 2015 Jan;9(1):76-83
Protease inhibitor-based triple therapy is highly effective for hepatitis C recurrence after liver transplant: a multicenter experience.
Ann Hepatol. 2014 Sep-Oct;13(5):525-32